Detalhe da pesquisa
1.
High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study.
BMC Cancer
; 6: 94, 2006 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-16620378
2.
The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma.
Med Oncol
; 22(1): 29-38, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15750194
3.
A retrospective study focusing on clinical predictive factors in 126 patients with oesophageal carcinoma.
Anticancer Res
; 24(3b): 1915-20, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15274376
4.
The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.
In Vivo
; 18(5): 615-20, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15523902
5.
Esophageal cancer: current and emerging therapy modalities.
Expert Rev Anticancer Ther
; 8(9): 1433-48, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18759695
6.
Telomerase activity is not a key determinant of sensitivity to standard cytotoxic drugs in human esophageal carcinoma cell lines.
Anticancer Drugs
; 17(5): 503-9, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16702806